Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.

Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G; EAGLE Study Group.

Am J Kidney Dis. 2019 Mar 28. pii: S0272-6386(19)30100-3. doi: 10.1053/j.ajkd.2018.12.046. [Epub ahead of print]

PMID:
30929851
2.

Urinary proteome signature of Renal Cysts and Diabetes syndrome in children.

Ricci P, Magalhães P, Krochmal M, Pejchinovski M, Daina E, Caruso MR, Goea L, Belczacka I, Remuzzi G, Umbhauer M, Drube J, Pape L, Mischak H, Decramer S, Schaefer F, Schanstra JP, Cereghini S, Zürbig P.

Sci Rep. 2019 Feb 18;9(1):2225. doi: 10.1038/s41598-019-38713-5.

3.

Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.

Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G; Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi.

J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13.

4.

Rare Diseases in Europe: from a Wide to a Local Perspective.

Baldovino S, Moliner AM, Taruscio D, Daina E, Roccatello D.

Isr Med Assoc J. 2016 Jun;18(6):359-63. Review.

5.

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.

Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G.

Mol Immunol. 2016 Mar;71:131-142. doi: 10.1016/j.molimm.2016.01.010. Epub 2016 Feb 16.

PMID:
26895476
6.

Liver transplantation for aHUS: still needed in the eculizumab era?

Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.

Pediatr Nephrol. 2016 May;31(5):759-68. doi: 10.1007/s00467-015-3278-0. Epub 2015 Nov 24.

7.

Epidemiology And Healthcare Services Utilization for Rare Diseases In Italy.

Polistena B, Spandonaro F, Zocchetti C, Daina E.

Value Health. 2015 Nov;18(7):A681. doi: 10.1016/j.jval.2015.09.2029. Epub 2015 Oct 20. No abstract available.

8.

A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort study.

Daina E, Cravedi P, Alpa M, Roccatello D, Gamba S, Perna A, Gaspari F, Remuzzi G, Ruggenenti P.

Nephron. 2015;130(1):13-20. doi: 10.1159/000381480. Epub 2015 Apr 21.

9.

Monogenic diseases that can be cured by liver transplantation.

Fagiuoli S, Daina E, D'Antiga L, Colledan M, Remuzzi G.

J Hepatol. 2013 Sep;59(3):595-612. doi: 10.1016/j.jhep.2013.04.004. Epub 2013 Apr 8. Review.

10.

Discordant phenotype in monozygotic twins with renal coloboma syndrome and a PAX2 mutation.

Iatropoulos P, Daina E, Mele C, Maranta R, Remuzzi G, Noris M.

Pediatr Nephrol. 2012 Oct;27(10):1989-93. doi: 10.1007/s00467-012-2205-x. Epub 2012 Jun 4.

PMID:
22660956
11.

Eculizumab in a patient with dense-deposit disease.

Daina E, Noris M, Remuzzi G.

N Engl J Med. 2012 Mar 22;366(12):1161-3. doi: 10.1056/NEJMc1112273. No abstract available. Erratum in: N Engl J Med. 2012 Apr 12;366(15):1454.

PMID:
22435382
12.

Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.

Buscarini E, Leandro G, Conte D, Danesino C, Daina E, Manfredi G, Lupinacci G, Brambilla G, Menozzi F, De Grazia F, Gazzaniga P, Inama G, Bonardi R, Blotta P, Forner P, Olivieri C, Perna A, Grosso M, Pongiglione G, Boccardi E, Pagella F, Rossi G, Zambelli A.

Dig Dis Sci. 2011 Jul;56(7):2166-78. doi: 10.1007/s10620-011-1585-2. Epub 2011 Feb 3.

13.

Rare autoimmune diseases.

Schieppati A, Daina E.

Adv Exp Med Biol. 2010;686:365-74. doi: 10.1007/978-90-481-9485-8_21. Review.

PMID:
20824456
14.

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1844-59. doi: 10.2215/CJN.02210310. Epub 2010 Jul 1.

15.

Enzyme replacement therapy and Fabry nephropathy.

Warnock DG, Daina E, Remuzzi G, West M.

Clin J Am Soc Nephrol. 2010 Feb;5(2):371-8. doi: 10.2215/CJN.06900909. Epub 2009 Dec 10.

16.

Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.

Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M.

Thromb Haemost. 2009 Feb;101(2):233-8.

PMID:
19190804
17.

Why rare diseases are an important medical and social issue.

Schieppati A, Henter JI, Daina E, Aperia A.

Lancet. 2008 Jun 14;371(9629):2039-41. doi: 10.1016/S0140-6736(08)60872-7. Review. No abstract available.

PMID:
18555915
18.

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.

Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G; International Registry of Recurrent and Familial HUS/TTP.

Clin J Am Soc Nephrol. 2006 Jan;1(1):88-99. Epub 2005 Nov 2. Review.

19.

Introduction: hereditary hemorrhagic telangiectasia as a rare disease.

Daina E, D'Ovidio F, Sabbà C.

Curr Pharm Des. 2006;12(10):1171-2. Review.

PMID:
16611098
20.

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.

Galbusera M, Bresin E, Noris M, Gastoldi S, Belotti D, Capoferri C, Daina E, Perseghin P, Scheiflinger F, Fakhouri F, Grünfeld JP, Pogliani E, Remuzzi G.

Blood. 2005 Aug 1;106(3):925-8. Epub 2005 Apr 12.

21.

Takayasu's arteritis: A study of 104 Italian patients.

Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G; Itaka Study Group.

Arthritis Rheum. 2005 Feb 15;53(1):100-7.

22.

Left main stem patch plasty and aortic root homograft in Takayasu's disease.

Matteucci ML, Iascone M, Gamba A, Daina E, Rescigno G, Senni M, Ferrazzi P.

Ann Thorac Surg. 2004 Jan;77(1):314-7.

PMID:
14726087
23.

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.

Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G, Noris M; International Registry of Recurrent and Familial HUS/TTP.

Hum Mol Genet. 2003 Dec 15;12(24):3385-95. Epub 2003 Oct 28.

PMID:
14583443
24.

Tackling the problem of rare diseases in public health: the Italian approach.

Taruscio D, Ido MS, Daina E, Schieppati A.

Community Genet. 2003;6(2):123-4. No abstract available.

PMID:
14560074
25.

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Remuzzi G, Galbusera M, Noris M, Canciani MT, Daina E, Bresin E, Contaretti S, Caprioli J, Gamba S, Ruggenenti P, Perico N, Mannucci PM; Italian Registry of Recurrent and Familial HUS/TTP. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.

Blood. 2002 Aug 1;100(3):778-85.

26.

The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M; Itaslian Registry of Familial and Recurrent HUS/TTP.

J Am Soc Nephrol. 2001 Feb;12(2):297-307.

27.

Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?

Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G.

Circulation. 1999 Jul 6;100(1):55-60.

PMID:
10393681
28.

Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases.

Daina E, Schieppati A, Remuzzi G.

Ann Intern Med. 1999 Mar 2;130(5):422-6.

PMID:
10068416
29.

An information center for rare diseases: a tool for epidemiologic and clinical studies in rare diseases.

Daina E, Vasile B, Fiacco F, Minetti L, Schieppati A.

Contrib Nephrol. 1997;122:207-10. No abstract available.

PMID:
9399069
30.

Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.

Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, Daina E, Remuzzi G.

J Am Soc Nephrol. 1995 Aug;6(2):257-63.

31.

Rare diseases and orphan drugs.

Daina E.

Lancet. 1994 Jun 18;343(8912):1560-1. No abstract available.

PMID:
7911879
32.

Methylprednisolone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis.

Rota S, Rambaldi A, Gaspari F, Noris M, Daina E, Benigni A, Perna A, Donadelli R, Remuzzi G, Garattini S.

Kidney Int. 1992 Oct;42(4):981-90.

Supplemental Content

Support Center